Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Jan Chlumsky, Vladimir Zindr, Jana Kocianova, Jaromir Zatloukal, Katerina Neumannova, Jakub Zatloukal, Vratislav Sedlak, Jaroslav Zak, Karel Hejduk, Barbora Novotna. GOLD and phenotypes: The new Czech COPD guidelines. Eur Respir J 2015; 46: Suppl. 59, 3937

Member's Comments

No comment yet.

Related content which might interest you: COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Hospital adherence to GOLD guidelines for COPD exacerbation. Results of the European CODP audit Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013 CAT in COPD phenotypes (POPE study) Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 RT protocol reduces AECOPD readmissions Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Implementation of COPD phenotypes in real life Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014